GlassScriptPhysician profile
Jacob Cameron Mcneel
NPI 1003839663
$1,457.91
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $290 · 2021: $701 · 2022: $74.48.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $194.19 | 2021-2022 | |
| Lilly USA, LLC | $167.01 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.97 | 2019-2022 | |
| Amgen INC. | $100.56 | 2019-2021 | |
| Astellas Pharma US INC | $99.95 | 2021 | |
| Glaxosmithkline, LLC. | $94.09 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $90.12 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $86.26 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.94 | 2020-2021 | |
| Pfizer INC. | $81.97 | 2019-2021 | |
| Allergan, INC. | $55.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.76 | 2019-2020 | |
| Abbott Laboratories | $30.25 | 2021 | |
| Amarin Pharma, INC. | $27.20 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $24.78 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.47 | 2019 | |
| Dexcom, INC. | $22.08 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $17.79 | 2021 | |
| Merck Sharp & Dohme LLC | $15.99 | 2021 | |
| Horizon Therapeutics Plc | $14.37 | 2022 | |
| Novo Nordisk INC | $14.17 | 2019 | |
| Eisai INC. | $12.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Mcneel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.